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Abstract
Estrogen	receptor	(ER)	activity	regulates	diverse	physiological	processes	via	transcriptional
modulation	of	target	genes	[1].	The	selection	of	target	genes	and	the	magnitude	of	the	response,	be	it
induction	or	repression,	are	determined	by	many	factors,	including	the	effect	of	the	hormone	ligand
and	DNA	binding	on	ER	structural	conformation,	and	the	local	cellular	regulatory	environment.	The
cellular	environment	defines	the	specific	complement	of	DNA	enhancer	and	promoter	elements
present	and	the	availability	of	coregulators	to	form	functional	transcription	complexes.	Together,
these	determinants	control	the	resulting	biological	response.
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